MaxCyte, Inc.

MXCT · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$12-$12-$10-$11
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$2-$2-$8-$2
Other Non-Cash$2$3$2$3
Operating Cash Flow-$7-$10-$14-$8
Investing Activities
PP&E Inv.-$0-$1-$1-$0
Net Acquisitions$0$0-$2$0
Inv. Purchases-$35-$29-$35-$33
Inv. Sales/Matur.$40$31$47$31
Other Inv. Act.$0$0$0$0
Investing Cash Flow$5$2$10-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$2-$8-$4-$9
Supplemental Information
Beg. Cash$15$23$28$37
End Cash$13$15$23$28
Free Cash Flow-$8-$10-$15-$8
MaxCyte, Inc. (MXCT) Financial Statements & Key Stats | AlphaPilot